Drug Inventory List

Biologics by McKesson is proud to offer more than 130 therapies that represent the leading edge in treatment for cancer and rare and complex diseases. To ensure patients receive the education and support they need during treatment, many of these advanced drugs are available through Limited Distribution or Biologics Exclusive Distribution only. 

Limited Distribution

Biologics Exclusive Distribution

Covered by Medicare Part B

Download a PDF or view the list below.

BRAIN

BRAND NAMEGENERIC NAME
Gleostinelomustine
Matulaneprocarbazine hydrochloride
Temodar temozolomide

BREAST

BRAND NAMEGENERIC NAME
Afinitoreverolimus
Anastrozoleanastrozole
Aromasinexemestane
Everolimuseverolimus
Femaraletrozole
Ibrance palbociclib
Kisqaliribociclib
Lynparza olaparib
Megacemegestrol
Methotrexate methotrexate
Nerlynx neratinib
Piqray alpelisib
Soltamoxtamoxifen
Talzenna talazoparib
Tukysa tucatinib
Tykerblapatinib
Verzenio abemaciclib
Xeloda capecitabine

GASTROINTESTINAL (Bowel, Colon, Liver, Colorectal, Pancreas, Esophagus, Gallbladder)

BRAND NAMEGENERIC NAME
Afinitoreverolimus
Ayvakit avapritinib
Braftovi encorafenib
Lenvima lenvatinib
Lonsurf trifluridine and tipiracil
Lynparza lenvatinib
Nexavar sorafenib
Pemazyre pemigatinib
Qinlock ripretinib
Stivarga regorafenib
Sutent sunitinib
Tarceva erlotinib
Xelodacapecitabine
Xermelo telotristat ethyl

GENITOURINARY (Bladder, Prostate, Renal)

BRAND NAMEGENERIC NAME
Afinitoreverolimus
Cabometyx cabozantinib
Casodexbicalutamide
Erleada apalutamide
Inlyta axitinib
Lenvima lenvatinib
Lupronleuprolide
Lynparza olaparib
Nexavar sorafenib
Nilandronnilutamide
Nubeqa darolutamide
Rapamunesirolimus
Rubraca rucaparib
Sutent sunitinib
Votrientpazopanib
Xtandi enzalutamide
Yonsaabiraterone acetate
Zytigaabiraterone acetate

GYN ONC

BRAND NAMEGENERIC NAME
Hexalenaltretamine
Hydreahydroxyurea
Lenvima lenvatinib
Lynparza olaparib
Rubraca rucaparib
Zejula niraparib

HEAD, NECK & THYROID

BRAND NAMEGENERIC NAME
Caprelsa vandetanib
Hydreahydroxyurea
Lenvima lenvatinib
Nexavar sorafenib

HEMATOLOGIC

BRAND NAMEGENERIC NAME
6-TGthioguanine
Agrylinanagrelide HCL
Alkeran melphalan
Bosulif bosutinib
Brukinsa zanubrutinib
Calquence acalabrutinib
Copiktra duvelisib
Cytoxan cyclophosphamide
Doptelet avatrombopag
Farydakpanobinostat
Gleevecimatinib mesylate
Hydreahydroxyurea
Idhifa enasidenib
Imbruvica ibrutinib
Inqovi cedazuridine and decitabine
Inrebic fedratinib
Jakafi ruxolitinib
Leucovorin calciumleucovorin calcium
Leukeranchlorambucil
Methotrexatemethotrexate
Myleran busulfan
Ninlaro ixazomib
Onuregazacitidine
Pomalyst pomalidomide
Promactaeltrombopag
Purinetholmercaptopurine
Revlimid lenalidomide
Rydaptmidostaurin
Spryceldasatinib
Targretinbexarotene
Tasignanilotinib
Tavalisse fostamatinib
Thalomid thalidomide
Tibsovo ivosidenib
Tretinointretinoin
Venclexta venetoclax
Xospata gilteritinib
Xpovio selinexor
Zydelig idelalisib

LUNG

BRAND NAMEGENERIC NAME
Afinitoreverolimus
Alecensa alectinib
Alunbrig brigatinib
Gavreto pralsetinib
Cotellic cobimetinib
Hycamtin topotecan
Iressa gefitinib
Lorbrena lorlatinib
Methotrexatemethotrexate
Rozlytrek entrectinib
Tagrisso osimertinib
Tarceva erlotinib
Vepesid etoposide
Vizimpro dacomitinib
Xalkori crizotinib
Zykadiaceritinib

MELANOMA & BASAL CELL

BRAND NAMEGENERIC NAME
Braftovi encorafenib
Cotellic cobimetinib
Erivedge vismodegib
Mekinisttrametinib
Mektovi binimetinib
Odomzosonidegib
Tafinlardabrafenib
Zelboraf vemurafenib

OTHER

BRAND NAMEGENERIC NAME
Lysodrenmitotane
Mesnexmesna
Methotrexatemethotrexate
Methylprednisolonemethylprednisolone
Prednisoneprednisone
Pomalyst pomalidomide
Thalomid thalidomide

RARE & COMPLEX THERAPIES

BRAND NAMEGENERIC NAME
Cablivi caplacizumab
Enspryng satralizumab
Gamifant emapalumab
Kineret anakinra
Turalio pexidartinib

SUPPORTIVE

BRAND NAMEGENERIC NAME
Compazineprochlorperazine
Decadron Dexamethasone
Emend aprepitant
Kytril granisetron HCL
Neulastapegfilgrastim
Neupogenfilgrastim
Noxafilposaconazole
Phenerganpromethazine
Prednisoneprednisone
Sancusogranisetron transdermal patch
Varubi rolapitant
Zofran ondansetron

INTRAVENOUS

BRAND NAMEGENERIC NAME
Bavencio avelumab
Besponsa inotuzumab ozogamicin
Cyramza ramucirumab
Enhertu trastuzumab deruxtecan
Imfinzi durvalumab
Monjuvi tafasitamab
Mylotarg gemtuzumab ozogamici
Polivypolatuzumab vedotin
Portrazza necitumumab
Sarclisa isatuximab-irfc
Trodelvy sacituzumab govitecan-hziy
Vidazaazacytidine